Jeffrey S. Kennedy - Concepedia

Author

Jeffrey S. Kennedy

University of Massachusetts Chan Medical School

Also Known As

J S Kennedy, J. S. Kennedy, J.S. Kennedy, Jeffrey Kennedy, Jeffrey S Kennedy, Jeffrey S. Kennedy, Jeffrey S. Kennedy

Publications

2.8K

Citations

H-Index

Concepts

All Affiliations

University of Massachusetts Chan Medical School Saint Louis University University of Pennsylvania New York State Department of Health National Institute of Allergy and Infectious Diseases

About

Jeffrey S. Kennedy is an author at University of Massachusetts Chan Medical School specializing in immunology, medicine, and vaccination.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	16	1.4K
2	Immunology	16	16	1.4K
3	Allergy	2	2	237
4	Cell Biology	2	2	94
5	Clinical Immunology	1	1	28

Jeffrey S. Kennedy

Publications

2.4K

Citations

H-Index

Page 1

	Year	Citations
A randomized, controlled trial of IL-10 in humans. Inhibition of inflammatory cytokine production and immune responses. Amy Chernoff, Eric V. Granowitz, Leland Shapiro, The Journal of Immunology	1995	420
A live, attenuated recombinant West Nile virus vaccine Thomas P. Monath, Jian Liu, Niranjan Kanesa-thasan, Proceedings of the National Academy of Sciences VaccinationMolecular VirologyVaccine DevelopmentVaccine TargetPathogenesis	2006	226
Dose-Related Effects of Smallpox Vaccine Sharon E. Frey, Frances K. Newman, John Cruz, New England Journal of Medicine	2002	182
Cross-subtype antibody and cellular immune responses induced by a polyvalent DNA prime–protein boost HIV-1 vaccine in healthy human volunteers Shixia Wang, Jeffrey S. Kennedy, Kim West, Vaccine VaccinationPolyvalent DnaHuman RetrovirusImmunodeficienciesImmunology	2008	181
Clonal vaccinia virus grown in cell culture as a new smallpox vaccine Richard Weltzin, Jian Liu, Gwendolyn A. Myers, Nature Medicine VaccinationMucosal VaccinationClonal Vaccinia VirusVaccine DevelopmentVaccine Target	2003	154
Clinical and immunologic responses to multiple doses of IMVAMUNE® (Modified Vaccinia Ankara) followed by Dryvax® challenge Sharon E. Frey, Frances K. Newman, Jeffrey S. Kennedy, Vaccine VaccinationVaccinologyMucosal VaccinationAllergyVaccine Development	2007	121
Quantitation of CD8+ T Cell Responses to Newly Identified HLA-A*0201–restricted T Cell Epitopes Conserved Among Vaccinia and Variola (Smallpox) Viruses Masanori Terajima, John Cruz, Gregory Raines, The Journal of Experimental Medicine HistocompatibilityT Cell DeficienciesImmunologyAntigen ProcessingCd4 T Cell Responses	2003	116
Safety and Immunogenicity of LC16m8, an Attenuated Smallpox Vaccine in Vaccinia-Naive Adults Jeffrey S. Kennedy, Marc Gurwith, C. L. Dekker, The Journal of Infectious Diseases	2011	103
Cross-subtype antibody and cellular immune responses induced by a polyvalent DNA prime–protein boost HIV-1 vaccine in healthy human volunteers Shixia Wang, Jeffrey S. Kennedy, Kim West, Vaccine VaccinationPolyvalent DnaHuman RetrovirusImmunodeficienciesImmunology	2008	101
Comparison of the safety and immunogenicity of ACAM1000, ACAM2000 and Dryvax® in healthy vaccinia-naive adults Sharon E. Frey, Frances K. Newman, Jeffrey S. Kennedy, Vaccine VaccinationVaccine SafetyVaccinologyVaccine DevelopmentVaccine Surveillance	2008	91

Page 1